Poststorage leuko-depleted plasma inhibits T-cell proliferation and Th1 response in vitro: Characterization of TGFβ-1 as an important immunomodulatory component in stored blood

Transplantation

Volumn 80, Issue 1, 2005, Pages 95-101

  Hodge, Greg L ^a,b   Hodge, Sandra J ^b   Nairn, Judi ^a   Tippett, Emma ^a   Holmes, Mark ^b   Reynolds, Paul N ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Immunosuppression; Poststorage leuko depleted plasma; Th1 cytokines transforming growth factor beta; Transfusion

Indexed keywords

CD69 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4; TAU INTERFERON; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; PARAMETER; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; POSTOPERATIVE INFECTION; POSTSTORAGE LEUKO DEPLETED PLASMA; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; THROMBOCYTE;

APOPTOSIS; BLOOD SPECIMEN COLLECTION; BLOOD TRANSFUSION; CELL DIVISION; CELLS, CULTURED; CYTOKINES; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; LEUKOCYTES; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 22144441359     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000163866.43866.44     Document Type: Article

References (34)

1. Blumberg N. Allogenic transfusion and infection: economic and clinical implications. Semin Haem 1997; 34: 34.
2. Opelz G, Sengar DPS, Mickey MR, et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
3. Iwaki Y, Cecka JM, Terasaki PI. The transfusion effect in cadaver kidney transplant. Transplantation 1990; 49: 56.
4. Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clincal manifestations and mechanisms. Vox Sang 1998; 74: 315.
5. Blajchman MA, Bordin JO. Mechanism of transfusion-associated immunosuppression. Cur Opin Haem 1994; 1: 457.
6. Heiss MM, Allgayer H, Gruetzner KU, et al. Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients. Anticancer Res 1997; 17: 2637.
7. Opelz G, Terasaki PI. Poor kidney transplant survival in recipients with frozen blood transfusion or no transfusion. Lancet 1974; 2: 696.
8. Brunsen ME, Alexander JW. Mechanism of transfusion induced immunosuppression. Cur Opin Haem 1990; 1: 457.
9. Nickerson PW, Streurer W, Streiger J, et al. In pursuit of the "Holy Grail": allograft tolerance. Kidney Int 1994; 45: S40.
10. Mosmann T, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 7; No3, 138.
11. Gafter U, Kalechman Y, Orlin JB, et al. Anaemia of uremia is associated with reduced in-vitro cytokine secretion: immunopotentiating activity of red blood cells. Kidney Int. 1994; 45: 224.
12. Gafter U, Kalechman Y, Sredni B. Blood transfusion enhances production of T-helper-2 cytokines and transforming growth factor β in humans. Clin Science 1996; 91: 519.
13. Jonuleit H, Adema G, Schmitt E. Immune regulation by regulatory T cells: implications for transplantation. Transpl Immunol 2002; 11: 267.
14. Gorczynski RM, Hadini S, Clark DA. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol 2002; 48: 18.
15. Hodge G, Han P. Effect of Factor VIII concentrate on lymphocyte proliferation and apoptosis: TGFβ is a significant immunomodulatory component of FVIII. Br J Haem 2001; 115: 376.
16. Hodge G, Flower R, Han, P. Australian plasma-derived factor VIII concentrate inhibits Th1 type cytokines but increases Th2 type cytokine, IL-10. Br J Haem 2000; 109: 902.
17. Ghio M, Ottonello L, Contini P, et al. Transforming growth-β1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Transfusion Med 2003; 102: 1100.
18. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968; S21: 77.
19. Roberts AB, Sporn MB. The transforming growth factor-βs, in Sporn MB., Roberts A.B. (eds): Peptide Growth Factors and their Receptors. Handbook of Experimental Pharmacology. New York, NY, Springer-Verlag, 1990, p 419.
20. Hodge G, Hodge S, Haslam S, et al. Rapid detection of neonatal sepsis by simultaneous measurement of multiple cytokines using 100 μL sample volumes. Clin Exp Immunol 2004; 137: 402.
21. Hodge G, Lloyd JV, Hodge S, et al. Functional lymphocyte immunophenotypes observed in Thalassaemia and Haemophilia patients receiving current blood product preparations. Br J Haem 1999; 105: 817.
22. Williamson LM, Leucocyte depletion of the blood supply: how will patients benefit? Br J Haem 2000; 110: 256.
23. Barclay AN, Brown MH, Law ASK, et al. In: The Leucocyte Antigen Factsbook. (eds). Academic Press, London, 1997: 486.
24. Poggi A. In: Leucocyte Typing VI. Kishimoto, T., Kikutani, H. et al. (eds) Garland Publishing, New York, N.Y. 1998: 166.
25. Khaled AR, Durum SK. The role of cytokines in lymphocyte homeostasis. Biotechniques 2002: 33; S40.
26. Huleatt JW, Creswell J, Bottomly K, et al. P27kip1 regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawal. Immunol 2003; 108: 493.
27. Boussiotis VA, Barber DL, Nakarai T, et al. Prevention of T-cell anergy by signaling through the common gamma chain of the IL-2 receptor. Science 1994; 266: 1039.
28. Muro S, Taha R, Tsicopoulos A, et al. Expression of IL-15 in inflammatory pulmonary diseases. J Allergy Clin Immunol 2001; 108: 970.
29. Chik KW, Li K, Pong H, et al. Elevated serum interleukin-15 level in acute graft-versus-host disease after haemopoietic cell transplantation. J Paed Haem One. 2003; 25: 960.
30. Kalechman Y, Gafter U, Sobelman D, et al. The effect of a single whole-blood transfusion on cytokine secretion. J Clin Immunol 1990; 10: 99.
31. Espevik T, Figari IS, Shallaby MR, et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 1987; 166: 571.
32. Kuypers DR, Claes K, Evenpoel P, et al. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients. Clin Pharmacol Ther 2004; 75: 434.
33. Shapiro R. Low toxicity immunosuppressive protocols in renal transplantation. Keio J Med 2004; 53: 18.
34. Pirenne J, Koshiba T, Geboes K, et al. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Transplantation 2002; 73: 966.